'People are not happy': Presque Isle deals with swimming restrictions at Beaches 6 & 8
Their job has been to politely inform visitors that swimming has been restricted at the popular beaches due to consistently high levels of E. coli bacteria. No one has been allowed to swim at Beaches 6 and 8 since July 8.
"People are not happy and understandably so," said Matt Greene, the park's operations manager. "These are two of our most popular beaches and people have been going to them for a long time."
High E. coli levels are a concern because they indicate a significant amount of sewage or animal waste in the water that can give swimmers gastrointestinal illness or skin infections.
Park officials have been working with the Erie County Department of Health to figure out why levels are so high, and what can be done to lower them and once again allow people to swim at Beaches 6 and 8.
"Right now, we don't have an explanation," Greene said. "We haven't seen any unusual storms that cause run off from nearby streams, or significant bird activity at those beaches."
Though water samples taken at both beaches this week have not exceeded the daily limit of 999 E. coli particles per 100 milliliters of lake water, they have been high enough at both beaches to exceed the average, or geometric mean, of 126 particles over the previous 30 days of testing.
Beach 6's geometric mean was 146 on July 11, while Beach 8's was 127.8, Greene said.
"One good (testing) day could bring them down and allow us to lift the restrictions," Greene said.
The issue most days has been that one of the three daily samples taken at each beach has been high, which increases the beach's average. After a storm passes, the amount of E. coli in all three samples is usually elevated.
Some days a sample taken from the edge of a beach's swimming section is high, while other times it's a sample taken from the middle, Greene said.
Park officials are "crunching the numbers" to determine a reason for the high levels, Greene said. They are looking at several possible causes, including infrastructure problems and testing anomalies.
More: Swimming restricted for second straight day at two Presque Isle State Park beaches
Though swimming is currently not allowed at the park's two most popular beaches, park officials do have alternatives.
They have opened Beaches 1, 3, 7 and 10 for swimming in recent days, along with Beach 11, which is usually open for swimming. They might even open Beach 9 on weekends, Greene said.
"The bathrooms at those beaches are already open, so we just make sure the lifeguard operations are ready at those beaches," Greene said. "Beaches 6 and 8 are centrally located, though, and they are where we have put in so much infrastructure. We don't like having restrictions at all, but certainly not at those two beaches."
Contact David Bruce at dbruce@gannett.com. Follow him on X @ETNBruce.
This article originally appeared on Erie Times-News: No swimming at Presque Isle beaches still due to E. coli
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis
Longhorn's validated PrimeStore® MTM sample collection device and Promega Maxwell® instruments will be offered together to laboratories globally Longhorn and Promega to showcase combined offering at the Association for Diagnostics & Laboratory Medicine conference, July 29-31, 2025 BETHESDA, Md. & GAITHERSBURG, Md., July 28, 2025--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced a strategic co-marketing agreement with Promega Corporation to deliver integrated molecular testing solutions designed to enhance safety, efficiency and flexibility across a wide range of diagnostic settings. This collaboration brings together Longhorn's validated PrimeStore® Molecular Transport Medium (MTM) and Promega's Maxwell® automated nucleic acid extraction platform, delivering a powerful, end-to-end workflow to support an all-in-one solution for safer and enhanced virus sample collection, transportation and analysis. Longhorn's PrimeStore® MTM is an inactivating molecular transport medium for both RNA and DNA. The device delivers nucleic acid samples in a time-efficient manner with Promega's Maxwell® instruments and reagent kits, designed for the automated extraction of viral total nucleic acid from a range of sample types. "The accuracy of molecular diagnostics, PCR and sequencing, starts with high quality nucleic acid," said Longhorn Vaccine and Diagnostics President Jeff Fischer. "Promega has proven that PrimeStore® MTM does just that with validation testing on their Maxwell® platform. Samples are safe to handle outside of containment, speeding up the testing time and therefore speeding up the accurate treatment of patients. The Maxwell® platform and nucleic acid extraction kits are now being added to our Instructions for Use." "Together, these technologies streamline the workflow from sample collection to high-quality nucleic acid purification without compromising on safety or performance," said Promega Director of Applied Markets Julie Yang. Longhorn and Promega will showcase their combined technologies at the upcoming Association for Diagnostics & Laboratory Medicine conference (ADLM 2025) in Chicago from July 29-31, 2025. Visit booth #3757 to learn more about PrimeStore® MTM and booth #3655 to learn more about the Maxwell® instruments and nucleic acid purification kits. A joint poster showcasing how these technologies work together was presented at the May 2025 Association of Public Health Laboratories annual conference in Portland, Oregon, titled "Validation of a Novel Sample Collection-to-Detection Workflow Using PrimeStore® MTM, Pathogen Total Nucleic Acid Kit, and PrimeMix® MTB." A second joint poster was presented at the June 2025 International Symposium of the World Association of Veterinary Laboratory Diagnosticians conference in Calgary, Alberta, titled "Novel Biosafe and Scalable Detection of Influenza A (H5N1, H3N2, H1N1) for Veterinary and One Health Applications." For more information about Longhorn, visit About Longhorn Vaccines and DiagnosticsLonghorn Vaccines and Diagnostics is a closely held One Health company based in Maryland that is developing broad coverage vaccines and diagnostic tools for worldwide public health concerns such as anti-microbial resistance, sepsis and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing broad coverage vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn products play a significant role to surveil, diagnose, prevent and treat the next infectious disease. Longhorn's core diagnostic product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore® MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization. About Promega CorporationPromega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's portfolio of over 4,000 products supports a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. These tools and technologies have grown in their application over the last 45 years and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. View source version on Contacts Longhorn Vaccines and DiagnosticsJeffrey FischerEmail: jeff@ MediaAlexis Feinberg – ICR HealthcareEmail: Promega CorporationPenny PattersonE-mail: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Washington Post
4 hours ago
- Washington Post
Those annoying pharmaceutical ads have real value
Since stepping into the helm at the Department of Health and Human Services, Robert F. Kennedy Jr. has done his best to challenge traditional medicine. He has loosened vaccine recommendations for children and pregnant women, peddled baseless claims about the causes of chronic diseases, and championed alternative therapies such as 'healing farms.'


New York Times
6 hours ago
- New York Times
What Happens When Doctors Can't Trust the Government?
The other day I was talking to one of my patients about her vaccinations, and I noticed that she hadn't had a Covid-19 vaccine since the early days of the pandemic. 'The virus has changed so much since then,' I told her, 'so we recommend that you get the current vaccine——' And then I stopped dead in my tracks, the words 'we recommend' lingering in the air. This is how I'd always phrased these types of recommendations, but I was suddenly unsure of who the 'we' was. Up until recently, it meant a medical community that included not just my health care colleagues, but also the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, respected medical journals and the research community. It's not remotely feasible for practicing clinicians to review every medical study out there, so we rely on trusted colleagues and institutions with the relevant expertise to help guide us. The 'we' suddenly rang hollow. The institutions I trusted to be deliberative and evidence-based sources of knowledge that extend my medical abilities are no longer that. In the first Trump administration, despite relentless attacks from the president, the nation's public health institutions remained largely intact, if wearied. But the plunder of the second Trump administration has disemboweled them and installed fox-guarding-the-henhouse leadership. Medical professionals can no longer fully trust federal health guidance, and our patients are the ones who will suffer the most. For most of my colleagues and me, the C.D.C. and the N.I.H. were the medical Mount Olympus, the towering pillars of medical authority. Contrary to right-wing portrayals, these were not dictatorial authorities. These were earned authorities, comprising our best, brightest and most dedicated peers. The formidable talents of these doctors and scientists would have commanded enviable salaries had they taken jobs in industry, but they chose the public sector instead — something that we clinicians were forever grateful for. Were there egos, missteps and shortcomings? Sure. But by and large, the people I met who worked for the C.D.C. or N.I.H. were brilliant and rigorous, and cared passionately about the science they were pursuing. While there are some doctors who viewed our public health institutions with disdain — some of them now are running these very organizations — most practicing physicians relied heavily on them to deliver the best care possible to their patients, despite occasional quibbles. What a relief, I always felt, that there were people organizing the things I can't do — testing new treatments, conducting population studies, keeping tabs on worldwide diseases, issuing guidelines and more. Want all of The Times? Subscribe.